Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

entities : Teva pharmaceutical industries ltd    crawled date : 2022 - 04 - 04    save search

Teva to Host Conference Call to Discuss First Quarter 2022 Financial Results at 8 a.m. ET on May 3, 2022
Published: 2022-04-04 (Crawled : 21:00) - biospace.com/
TEVA | $13.06 0.38% 1.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.96% H: 4.75% C: 4.32%

conference results
Global Anti-Osteoporosis Therapy & Fracture Healing Market to 2027 - Featuring Actavis, Amgen and DJO Global Among Others
Published: 2022-04-04 (Crawled : 11:00) - prnewswire.com
GLAXF | News | $19.54 -3.77% 0 twitter stocktwits trandingview |
Health Technology
| | O: -3.27% H: 0.0% C: -3.52%
ZBH | $119.39 -1.47% 57K twitter stocktwits trandingview |
Health Technology
| | O: -0.63% H: 0.27% C: -0.84%
PFE | News 4 | $25.805 -1.77% 3.8M twitter stocktwits trandingview |
Health Technology
| | O: 0.41% H: 0.17% C: -1.62%
JNJ | News | $147.46 -0.72% 820K twitter stocktwits trandingview |
Health Technology
| | O: 0.55% H: 0.0% C: 0.0%
GSK | News | $40.93 0.17% 170K twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.0% C: 0.0%
LLY | News | $724.615 -1.04% 480K twitter stocktwits trandingview |
Health Technology
| | O: 0.03% H: 0.76% C: -0.45%
AMGN | News | $271.635 -0.5% 120K twitter stocktwits trandingview |
Health Technology
| | O: -0.12% H: 1.49% C: 0.84%

therapy market
FDA Accepts Dupixent® (dupilumab) for Priority Review in Patients Aged 12 Years and Older with Eosinophilic Esophagitis
Published: 2022-04-04 (Crawled : 06:00) - prnewswire.com
SNY | News | $49.085 5.31% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.76% H: 0.0% C: 0.0%
REGN | News | $894.9 -1.28% 80K twitter stocktwits trandingview |
Health Technology
| | O: 0.74% H: 0.6% C: -0.23%

dupixent fda review order
Press Release: FDA accepts Dupixent® (dupilumab) for Priority Review in patients aged 12 years and older with eosinophilic esophagitis
Published: 2022-04-04 (Crawled : 06:00) - globenewswire.com
SNY | News | $49.085 5.31% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: 0.76% H: 0.0% C: 0.0%
REGN | News | $894.9 -1.28% 80K twitter stocktwits trandingview |
Health Technology
| | O: 0.74% H: 0.6% C: -0.23%

dupixent fda review order
Gainers vs Losers
45% 55%

Top 10 Gainers
SGBX | $0.26 80.43% 54M twitter stocktwits trandingview |
Producer Manufacturing

LICN | $1.0 78.57% 3.3M twitter stocktwits trandingview |

CSSE 4 | $0.2656 74.39% 9.7M twitter stocktwits trandingview |
Consumer Services

BRFH 4 | $1.89 71.82% 32M twitter stocktwits trandingview |
Manufacturing

BOF | $1.95 66.67% 920K twitter stocktwits trandingview |

MTC | $3.62 61.61% 790K twitter stocktwits trandingview |
Technology Services

AMST | $3.13 56.5% 500K twitter stocktwits trandingview |
Technology Services

PCSA | $2.28 40.74% 37M twitter stocktwits trandingview |
Producer Manufacturing

EVA | $0.626 39.14% 2.3M twitter stocktwits trandingview |
Process Industries

OPTN | $1.215 31.31% 12M twitter stocktwits trandingview |
Health Services


Your saved searches
Save your searches and get alerts when important news are released.